![]() |
![]() |
![]() |
![]() |
1-PP | Quality of diagnosis and lab monitoring of people with hemophilia and other bleeding disorders across the continents: WFH IEQAS programme results over the last 8 years | Silmara Montalvao | ![]() |
![]() |
|||
3-PP | The genetic landscape of factor 8 in people with Haemophilia A from central South Africa | Jean Kloppers | ![]() |
![]() |
|||
4-PP | Inhibitor screening of hemophilia A patients at HTC at PIMS Pakistan | Farwa Sijjeel | ![]() |
![]() |
|||
5-PO | Genotype-phenotype analyses of Iranian patients with and without hemophilia B Leyden: A single-center study | Shadi Tabibian | ![]() |
![]() |
|||
8-PO | Innovation in Education: Interactive Model of Blood Clotting Cascade and Hemophilia | Ahmed Saeed | ![]() |
![]() |
|||
9-PP | WFH Programs in Eastern Mediterranean Region | Ellia Tootoonchian | ![]() |
![]() |
|||
11-PP | World Federation of Hemophilia (WFH) Path to Access to Care and Treatment (PACT) Program Advocacy Academy Global Impact | Salome Mekhuzla | ![]() |
![]() |
|||
12-PP | 50 years of history: key milestones in access to better treatment in Uruguay | Juan Andrés Pereira De Souza | ![]() |
![]() |
|||
14-PO | Generational exchange in Uruguay: lessons learnt and the key to success | Juan Andrés Pereira De Souza | ![]() |
![]() |
|||
15-PO | Women Now: Identify and register hemophilia carriers when no diagnosis is available | Isabel Sorondo | ![]() |
![]() |
|||
18-PP | Teaching Multidisciplinary Health Care Providers on Hemophilia and other Rare bleeding disorders in Kenya | IRENE KHAEMBA | ![]() |
![]() |
|||
21-PP | Prenatal testing versus Prophylaxis with newer drugs in severe haemophilia patients in India: cost assessment. | Rucha Patil | ![]() |
![]() |
|||
22-PP | Navigating Surgical Challenges: Best Practices for Managing Hemophilia Patients in the Operating Room | Prisha Nankana | ![]() |
![]() |
|||
23-PP | Overview of adults and children with hemophilia in Hemophilia Treatment Center of Sfax | Maha Charfi | ![]() |
![]() |
|||
25-PP | A proposal to measure the gross motor development of infants with haemophilia | Dimitrios Syrengelas | ![]() |
![]() |
|||
26-PP | Announcing the diagnosis of a benign chronic disease the case of hemophilia : A Moroccan Case Study | Mohamed El Khorassani | ![]() |
![]() |
|||
27-PO | Is there a silver lining in Glanzman Thrombasthenia after puberty? | Ahmad Tarawah | ![]() |
![]() |
|||
28-PO | FVIII Half-Life Products: a Real-World Experience | Ezio zanon | ![]() |
![]() |
|||
29-PP | Tunisian experience Center with Emicizumab | Ons Ghali | ![]() |
![]() |
|||
31-PP | Hematuria in Paediatric Hemophilia A Local Malaysian Experience (Main Centre) | Liana Yusof | ![]() |
![]() |
|||
33-PO | Ulcerative colitis in two brothers with severe haemophilia A | Monika Biernat | ![]() |
![]() |
|||
39-PO | Bilateral Haemophilic Pseudotumors in Both Thighs with Haemophilic Knee Arthropathy: A Twisted Parallelism | Pranav Keswani | ![]() |
![]() |
|||
40-PO | Complex Primary Total Knee Arthroplasty in Haemophilic Arthropathy with Extraarticular Deformity | Pranav Keswani | ![]() |
![]() |
|||
42-PO | Acquired hemophilia A Post-COVID-19 Vaccination successfully treated with low dose of rituximab | wafa chenbah | ![]() |
![]() |
|||
43-PP | The A-MOVE study easily explained: the value of regular joint assessments in individuals with haemophilia | Markus Fusser | ![]() |
![]() |
|||
44-PP | Long-term outcomes of prophylaxis with efanesoctocog alfa in adults and adolescents previously treated on demand: second interim analysis of XTEND-ed | Helena Palmborg | ![]() |
![]() |
|||
45-PP | Plain language summary of two-year results of weekly efanesoctocog alfa treatment in children with severe haemophilia A: Interim analysis of the XTEND-ed phase 3 study | Graham Neill | ![]() |
![]() |
|||
46-PP | Plain language summary: Efanesoctocog alfa treatment outcomes over 3 years in adults & adolescents with severe haemophilia A in the long-term XTEND-ed study | Elena Santagostino | ![]() |
![]() |
|||
47-PP | A Natural History Study of Bleeding Symptoms and Treatment Outcomes in Patients with Glanzmann Thrombasthenia The Pakistan Site Experience | Shelby Domino | ![]() |
![]() |
|||
49-PP | Comparison of the haemorrhagic phenotype between female and male patients affected by Autosomal Inherited Bleeding Disorders in a single-centre cohort | Tiziano Martini | ![]() |
![]() |
|||
50-PP | A prospective, observational longitudinal study of functional outcome of radionuclide synoviorthesis in haemophilic arthropathy | Pranav Keswani | ![]() |
![]() |
|||
54-PP | The need to improve diagnostic capacity in low- middle-income countries: lessons from the WBDR and Nigeria as a case study | Ellia Tootoonchian | ![]() |
![]() |
|||
55-PP | Aziza Othmana HTC experience with hemophilia and World Bleeding Disorder Registry (WBDR) | Emna Gouider | ![]() |
![]() |
|||
56-PP | Hemophilia life stages and changes global survey for people with hemophilia, caregivers and hematologists: survey design and demographics | Tom Martin | ![]() |
![]() |
|||
57-PP | Innovative Approaches to Managing Hemophilia in Economically Disadvantaged Patients: Lessons from a Resource-Limited Setting | Vishakha Dongare | ![]() |
![]() |
|||
58-PP | Launch of the Economics and Patient Outcomes in China in Haemophilia (EPOCH) Study Online Platform and First Patient Enrolled | Brian OMahony | ![]() |
![]() |
|||
59-PP | Real-life demographic landscape of congenital hemophilia in Romania | Simina Pirv | ![]() |
![]() |
|||
60-PP | Knowledge Transfer Program in NMOs. Statistical analysis of our reality. | Antonio Gomez Cavallini | ![]() |
![]() |
|||
61-PO | WFH Initiative on Gene Editing for Hemophilia | Mayss Naccache | ![]() |
![]() |
|||
62-PO | Comprehensive care planning for commercial gene therapy patients: Psychosocial, physical and medical considerations | Mosi Williams | ![]() |
![]() |
|||
63-PP | HEMCOSTING : A Customizable Cost-Effectiveness Microsimulation Model to Compare the Costs and Effects of Several Hemophilia A and B Treatment Strategies in Any Context | Nancy Bolous | ![]() |
![]() |
|||
64-PP | A Comprehensive Societal Costing Checklist to Guide Health Economic Analyses in Haemophilia | Nancy Bolous | ![]() |
![]() |
|||
65-PP | Is haemophilia classification restricting clinicians from providing optimal care for joint health in non-severe haemophilia? A case study series. | Alfie McBrien | ![]() |
![]() |
|||
66-PP | Knowledge, Attitudes, and Practices Regarding Home Based Treatment of Hemophilia Among Healthcare Professionals in Morocco | Fatima Zahra Ben Fouila | ![]() |
![]() |
|||
69-PP | HEAD-US and HJHS in Comparison with MRI for the Evaluation of Joint Health in Children with Haemophilia A: a Single Centre Experience | Athina Dettoraki | ![]() |
![]() |
|||
70-PP | The value of ultrasound in detecting subclinical abnormalities in joints of patients with hemophilia | Xinjuan Guo | ![]() |
![]() |
|||
72-PP | Clinical Application Value of the Chinese Expert Consensus on Ultrasound Assessment of Hemophilic Arthropathy | Jun Li | ![]() |
![]() |
|||
73-PP | Dual Immune Regulation: Exploring the Role of Regulatory T Cells and Regulatory B Cells in Modulating Inhibitor Development in people with Hemophilia A | Rashmi Kushwaha | ![]() |
![]() |
|||
76-PP | High responding inhibitors in patient with hemophilia: A single center experience in south Tunisia | Maha Charfi | ![]() |
![]() |
|||
80-PP | Thromboelastometry Clotting Profiles and Plasma Emicizumab Levels in Hemophilia A Patients on Low-Dose Emicizumab Prophylaxis for two to four years | Rucha Patil | ![]() |
![]() |
|||
81-PP | Usability evaluation of a novel point of care platform to simultaneously test FVIII activity and Thrombin generation | Aernoud Bavinck | ![]() |
![]() |
|||
82-PP | Turoctocog alpha Pegol in patients with Hemophilia A undergoing surgical procedures: A single center experience from North India | Akshay Middinti | ![]() |
![]() |
|||
83-PP | Cost-effectiveness and outcomes of radioactive synovectomy versus arthroscopy in hemophilic synovitis: a Brazilian perspective | Mariana Battazza | ![]() |
![]() |
|||
84-PP | The evaluation of sarcopenia in people with hemophilia over 40 years of age in Japan. | Kumiko Ono | ![]() |
![]() |
|||
85-PP | TKA in PwH at a Tertiary Care Centre- An experience with 112 patients with a medium term follow-up | Shubhranshu MOHANTY | ![]() |
![]() |
|||
86-PP | Total Hip replacement 50 years of experience in a single center | Maria Landro | ![]() |
![]() |
|||
87-PP | Joint Prosthetic Surgery in Patients with Hemophilia A: clinical-functional outcomes and quality of life | ezio zanon | ![]() |
![]() |
|||
88-PP | Extended tibial tuberosity osteotomy to facilitate implant removal in difficult knee revisions arthroplasty. Our experience with haemophilic patients | Dimitrios Kalatzis | ![]() |
![]() |
|||
91-PP | Postoperative outcomes of total knee arthroplasty in patients with hemophilic knee arthropathy a prospective study | Janie Barry | ![]() |
![]() |
|||
92-PP | Musculoskeletal complications in patients with hemophilia : A single-center experience | Maha Charfi | ![]() |
![]() |
|||
93-PO | Heterotopic ossification in Haemophilia: an 18-year single-centre case series | Adam Hussain | ![]() |
![]() |
|||
94-PP | Treatment of orthopedic complications of hemophilia in Azerbaijan | Mehpara Kazimova | ![]() |
![]() |
|||
95-PO | Major bleeding after Total Knee Replacement in PWH. How to avoid it | Maria Landro | ![]() |
![]() |
|||
96-PO | Efficacy of Treatment Modalities in Hemophilia Patients with Joint Pain: A Retrospective Analysis | Farwa Sijjeel | ![]() |
![]() |
|||
98-PP | Management of Perioperative Hemostasis in two patients with severe Hemophilia A with Inhibitors on Prophylaxis with Emicizumab using Global Hemostasis Assays | Gisela Barros Garcia | ![]() |
![]() |
|||
99-PP | Weekly Nordic Walking training improves joint health at one year in patients with haemophilia | Elena Anna Boccalandro | ![]() |
![]() |
|||
101-PP | Association between arthropathy and peripheral neuropathies in adults with hemophilia | Aidee Gibraltar Conde | ![]() |
![]() |
|||
102-PP | Conditioned pain modulation in patients with hemophilic arthropathy of the lower limbs. Multicentre cross-sectional cohort study. | Rubén Cuesta-Barriuso | ![]() |
![]() |
|||
103-PP | Finding the Right Flow: Acute Responses to Autoregulated vs. Non-Autoregulated Blood Flow Restriction in Elbow Rehabilitation for Hemophilia | Joaquín Calatayud | ![]() |
![]() |
|||
104-PP | Neuromotor reprogramming in people with Hemophilia (Allyane Method) | Mauro Dyntino | ![]() |
![]() |
|||
105-PP | Blood flow restriction in patients with hemophilic arthropathy. A pilot safety study | Rubén Cuesta-Barriuso | ![]() |
![]() |
|||
106-PP | Expanding HJHS: a full body assessment may provide more information on musculoskeletal health | Elena Anna Boccalandro | ![]() |
![]() |
|||
107-PP | Spinal Stenosis: The need to adapt physiotherapy approaches to older persons with haemophilia | Mark Mcgowan | ![]() |
![]() |
|||
108-PP | Creating physiotherapy guidelines for the management of iliopsoas haematomas in people with bleeding disorders | Richard Davis | ![]() |
![]() |
|||
109-PP | Comparative Efficacy of Guided Physical Therapy and Home-Based Care on Joint Health and Physical Function in Patients with Mild Hemophilia | Sandeep Kumar | ![]() |
![]() |
|||
110-PP | Overview Joint Health Status in haemophilia patients: a single Centre experience in Argentina | Estanislao Vera Santos | ![]() |
![]() |
|||
111-PP | Intra-articular injection of platelet-rich plasma (PRP) in addition to hyaluronic acid (HA) in the treatment of hemophilic artropathy | Cecilia Gallardo | ![]() |
![]() |
|||
112-PP | Comprehensive Rehabilitation Plan (RP) for Haemophilia Patients: Enhancing Joint Mobility, Quality of Life and Long-Term Stability | Martin Kaal | ![]() |
![]() |
|||
113-PO | Clinical Impact Of Recurrent Bleeding Episode On Joint Health And Functional Independence In Factor Vll Deficiency: A Retrospective Cause Report | Adithya TS | ![]() |
![]() |
|||
115-PO | Physiotherapy clinic: a single-center experience in musculoskeletal health management for patients with haemophilia | Elena Anna Boccalandro | ![]() |
![]() |
|||
116-PO | IMPACT OF PHYSIOTHERAPY ON HEMOPHILIC JOINT HEALTH SCORE | Manisha Syal | ![]() |
![]() |
|||
117-PO | EFFECT OF TAILOR-MADE EXERCISE PROTOCOL ON JOINT HEALTH AND PHYSICAL ACTIVITY IN CHILDREN WITH HEMOPHILIA | Smati Sambyal | ![]() |
![]() |
|||
118-PP | Standard dose Vs Low dose Emicizumab Prophylaxis in patients with Hemophilia A with Inhibitors - Single centre, Prospective Observational study | Shailendra Verma | ![]() |
![]() |
|||
119-PP | REAL-WORLD EXPERIENCE OF PROPHYLAXIS WITH EMICIZUMAB IN CHILDREN WITH HAEMOPHILIA A: A SINGLE CENTRE EXPERIENCE | Athina Dettoraki | ![]() |
![]() |
|||
120-PP | Nonacog beta pegol prophylaxis in pediatric patients with severe Hemophilia B: A single centre experience from North India | Shailendra Verma | ![]() |
![]() |
|||
122-PO | Denial of Prophylaxis in early adulthood leads to increased bleed rates and college absenteeism in a resource limited setting. | Rema Ganapathi | ![]() |
![]() |
|||
123-PO | Prophylactic treatment of hemophilia A patients in Azerbaijan | Gunel Alizade | ![]() |
![]() |
|||
124-PP | A pilot study investigating specific types of sexual difficulties in Tunisian Hemophiliacs. | wafa chenbah | ![]() |
![]() |
|||
125-PP | Degree of burden in primary caregivers of patients with hemophilia in Mexico | Ezequiel Martínez Martínez | ![]() |
![]() |
|||
126-PP | PACT Project: Empowering Women and Girls with Bleeding Disorders by Multidisciplinary Awareness and Psychosocial Support | Hina Fatima | ![]() |
![]() |
|||
127-PP | Walk and Talk Group: A supportive MDT community-based initiative for adults within the Bleeding Disorders Network Wales, UK | Kathleen Moore | ![]() |
![]() |
|||
128-PP | Psychological well-being of informal caregivers of people with coagulopathies in Mexico | Ezequiel Martínez Martínez | ![]() |
![]() |
|||
130-PP | A multidisciplinary nonmedical management approach to improve the quality of life of hemophilia, beyond medical treatment | Fariba Shokri | ![]() |
![]() |
|||
131-PP | Intra-articular injection of biological factors for the management of hemophilic arthropathy. | Dimitrios Kalatzis | ![]() |
![]() |
|||
132-PP | Quality of life of patients with hemophilia in Madagascar | Lindsay Kouatie Njonger | ![]() |
![]() |
|||
133-PP | Development of the Hemophilia Life Interference Questionnaire (HLIQ): A tool to evaluate the impact of hemophilia B and its treatment on patient lives | Sheena Thakkar | ![]() |
![]() |
|||
135-PP | Achieving Zero Annual Bleed Rate and Assessing Joint Health in Children with Hemophilia on Emicizumab Prophylaxis: Insights from a Low- and Middle-Income Country | Shigy Francis | ![]() |
![]() |
|||
136-PP | Successful Liver Transplantation in a Patient with Hemophilia A and Inhibitors: A Case Report | Abdulrahman Nasiri | ![]() |
![]() |
|||
137-PP | Treatment adherence, satisfaction and quality of life in adult patients with hemophilia A: A real-world survey of physicians and patients in the Kingdom of Saudi Arabia | Sheena Thakkar | ![]() |
![]() |
|||
138-PP | Prevalence of Depression in Adults with Hemophilia Using the Patient Health Questionnaire-9 (PHQ-9) | wafa chenbah | ![]() |
![]() |
|||
139-PP | Impact of Home Education and Self-Management Strategies on Quality-of-Life in Patients with Hemophilia: Preliminary Report of a Systematic Review and Meta-Analysis of Randomized Controlled Trials | Jose Santacruz-Arias | ![]() |
![]() |
|||
140-PO | Sports participation and psychosocial condition of patients with haemophilia in Hong Kong | Henry Hon-Wai Lam | ![]() |
![]() |
|||
141-PO | Assessment of Quality of Life in Tunisian Hemophilia Patients Using the EQ-5D Questionnaire | wafa chenbah | ![]() |
![]() |
|||
142-PO | Impact of Bernard-Soulier Syndrome on Patient Quality of life::A comprehensive Assessment using EQ-5D-5LTool | AJAI THOMAS | ![]() |
![]() |
|||
144-PP | Real-world effectiveness and safety of damoctocog alfa pegol in patients with a history of inhibitors: Fifth interim analysis of the HEM-POWR study | Amanda Ward | ![]() |
![]() |
|||
145-PP | Fifth interim analysis of the HEM-POWR study: A post hoc analysis of real-world effectiveness and safety of damoctocog alfa pegol in patients with mild and moderate haemophilia A | Amanda Ward | ![]() |
![]() |
|||
146-PP | Real-world effectiveness and safety of damoctocog alfa pegol in adolescent and older patients with haemophilia A in the fifth interim analysis of the HEM-POWR study | Amanda Ward | ![]() |
![]() |
|||
147-PP | The role of global hemostasis testing in the diagnosis and management of rare bleeding disorders: A six-year experience from a single tertiary care center in Kerala | Bitty Kurian | ![]() |
![]() |
|||
148-PP | Characteristics of Factor XIII Deficiency in Childhood: A Retrospective Study in Medina, Saudi Arabia | Noura Alsaid | ![]() |
![]() |
|||
149-PP | PATIENTS WITH PLATELET DISORDERS IN TUNISIA: WHERE ARE WE? | Meriem Achour | ![]() |
![]() |
|||
150-PP | Revolutionizing Rare Bleeding Disorder Management with Prophylactic Factor Replacement: Experience from a Tertiary care Centre in North India | Prisha Nankana | ![]() |
![]() |
|||
151-PP | Clinical phenotype, Thromboembolic complication and quality of life in a cohort of patients with afibrinogenemia | Meriem Bensadok | ![]() |
![]() |
|||
152-PP | Clinical spectrum and treatment outcomes of Rare Bleeding Disorders in females: A two-center experience in North Pakistan | muhammad usman | ![]() |
![]() |
|||
155-PP | Epidemiological and clinical-biological aspects of factor XIII deficiency in southern Tunisia | Imen Frikha | ![]() |
![]() |
|||
158-PO | Unveiling the Spectrum: Rare Bleeding Disorders in Eastern Uttar Pradesh, India | Rashmi Kushwaha | ![]() |
![]() |
|||
161-PO | MUSCULOSKELETAL LESIONS IN PATIENTS WITH FVII DEFICIENCY: EXPERIENCE IN VENEZUELA | Apsara Boadas | ![]() |
![]() |
|||
162-PO | Perioperative management for patients with congenital factor VII deficiency | IMEN Ben amor | ![]() |
![]() |
|||
165-PP | Quality of care for Hemophilia in Colombia: Ten Years of the Colombian Hemophilia Registry | Adriana Linares | ![]() |
![]() |
|||
166-PP | Effectiveness of post physiotherapy Gym protocol in enhancing fitness, psycho social well being and self confidence in young adult patients with hemophilia: a pilot Study | Geeta Suri Sharma | ![]() |
![]() |
|||
168-PP | Experience in treatment patients with severe hemophilia A who receving emicizumab during musculoskeletal surgeries | Tatyana Polyanskaya | ![]() |
![]() |
|||
169-PP | Giant hemophilic pseudotumor of the femur: 2-stages hip disarticulation | Ignacio Soncini | ![]() |
![]() |
|||
170-PO | Patient-Specific Cutting Guides for Total Knee Arthroplasty in Hemophilic Patients: A Surgeon-Driven Solution for Precision and Hemostasis | Salim Fourmas | ![]() |
![]() |
|||
171-PO | Effectiveness and advantages of Turoctocog alfa pegol in the perioperative management of cardiac surgery in a patient with mild hemophilia A | ezio zanon | ![]() |
![]() |
|||
172-PO | Long-term outcome of postoperative Range of Motion in Total Knee Replacement | Carla Daffunchio | ![]() |
![]() |
|||
173-PO | Evolution of Surgical Management and Multidisciplinary Care in Hemophilia: A 15-Year Retrospective Analysis | Salim Fourmas | ![]() |
![]() |
|||
175-PO | Minimally invasive treatment for orthopaedic pathology. 40 years of experience. | Maria Landro | ![]() |
![]() |
|||
176-PO | Detection of ankle joint microbleeds with magnetic resonance imaging in patients with severe haemophilia A on prophylactic treatment | Polona Klavar | ![]() |
![]() |
|||
177-PO | Observational and Phase 1 studies in the Development of Novel Therapies for Von Willebrand Disease: The VELORA Research Program | Jigar Amin | ![]() |
![]() |
|||
178-PO | A Phase 2 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of HMB-001 in Glanzmann Thrombasthenia: A Trial in Progress | Jigar Amin | ![]() |
![]() |
|||
179-PO | SHINE study design: An interventional, open-label, Phase 4 study investigating changes in synovial hypertrophy in patients with haemophilia A on efanesoctocog alfa prophylaxis | Sana Yaar | ![]() |
![]() |
|||
180-PP | Comprehensive analysis of demographic and clinical profiles in people with von willebrand disease: insights from the WFH World Bleeding Disorders Registry | Donna Coffin | ![]() |
![]() |
|||
181-PP | Von Willebrand disease follow-up and WBDR | Ons Ghali | ![]() |
![]() |
|||
182-PO | Gynecological Bleeding in Women with Congenital Bleeding Disorders: A Comprehensive Cohort from Iran | Shadi Tabibian | ![]() |
![]() |
|||
183-PO | Clinical and Treatment Features of Von Willebrand Deficiency | Huseyin Avni Solgun | ![]() |
![]() |
|||
185-PP | Joint status of Women with bleeding disorders | Carla Daffunchio | ![]() |
![]() |
|||
186-PP | Audit of the Management of Heavy Menstrual Bleeding in Women and Girls with Inherited Bleeding Disorders | Lugain Abdalla | ![]() |
![]() |
|||
187-PP | Development of Women, Girls, and People Who Have or Had the Potential to Menstruate (WGPPM) questionnaire for PROBE study | Dawn Rotellini | ![]() |
![]() |
|||
188-PP | Impact of bleeding on physical activity amongst Women and Girls with Bleeding Disorders in Ireland | Megan Kennedy | ![]() |
![]() |
|||
189-PP | SCREENING OF BLEEDING DISORDERS IN ADOLESCENTS /YOUNG ADULT WOMEN PRESENTING WITH HEAVY MENSTRUAL BLEEDING-A PROSPECTIVE STUDY FROM A SINGLE TERTIARY CARE CENTRE IN KERALA | Bitty Kurian | ![]() |
![]() |
|||
190-PP | Enhancing the Diagnosis of Hemophilia Carriers in Tunisia, Do we need molecular study? È | Eya Drissi | ![]() |
![]() |
|||
191-PP | Hemophilia Foundation of Michigans National Womens Conference: Empowering Change: Transforming Awareness, Advocacy and Care for Women with Hemophilia and Rare Factor Deficiencies | Susan Lerch | ![]() |
![]() |
|||
192-PP | Bleeding manifestations in haemophilia carriers in India | Sharda Shanbhag | ![]() |
![]() |
|||
194-PP | Gynecological and obstetrical hemorrhages in Women with rare bleeding disorders | Nawel Ferroudj | ![]() |
![]() |
|||
195-PP | Gender differences in bleeding disorders in Aziza Othmana HTC from Tunisia | Emna Gouider | ![]() |
![]() |
23-25 April 2025 Dubai
![]() |
Digital Object Identifier. Official code used to identify documents published on internet; similar to ISBN for books. You may use this code to reference your poster in future scientific publications or CVs. It can be found from anywhere in the world. ![]() To find the poster page, log onto www.medra.org and enter the DOI, or enter in your internet browser https://dx.doi.org/ followed by the DOI string asigned to your congress. ![]() |
![]() |
||
![]() |
|